Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 20, 2025, Relmada Therapeutics (RLMD) has a market cap of $9.619 million USD. According to our data, Relmada Therapeutics is ranked No.8823 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 20, 2025 | $9.62 M |
-38.70%
|
| Dec 31, 2024 | $15.69 M |
-87.44%
|
| Dec 29, 2023 | $0.12 B |
18.62%
|
| Dec 30, 2022 | $0.11 B |
-84.51%
|
| Dec 31, 2021 | $0.68 B |
-29.75%
|
| Dec 31, 2020 | $0.97 B |
-17.77%
|
| Dec 31, 2019 | $1.18 B |
747.83%
|
| Dec 31, 2018 | $0.14 B |
53.33%
|
| Dec 29, 2017 | $90.52 M |
-31.19%
|
| Dec 30, 2016 | $0.13 B |
-56.40%
|
| Dec 31, 2015 | $0.30 B |
-83.87%
|
| Dec 31, 2014 | $1.87 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Johnson & Johnson
JNJ
|
$379.48 B |
-0.003 M
|
USA
|
 Pfizer
PFE
|
$125.57 B |
0.001 M
|
USA
|
 Eli Lilly
LLY
|
$754.27 B |
0.008 M
|
USA
|
 AbbVie
ABBV
|
$306.02 B |
0.008 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$100.17 B |
-0.004 M
|
USA
|
 Merck
MRK
|
$196.28 B |
0.008 M
|
USA
|
 Amgen
AMGN
|
$149.09 B |
0.124 B
|
USA
|
 Gilead Sciences
GILD
|
$130.32 B |
-0.001 M
|
USA
|
 Biogen
BIIB
|
$17.36 B |
-0.001 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$61.57 B |
1.023 B
|
USA
|
 Alkermes
ALKS
|
$4.45 B |
-0.000 M
|
Ireland
|
 Jazz Pharmaceuticals
JAZZ
|
$6.24 B |
0.000 M
|
Ireland
|
 Sage Therapeutics
SAGE
|
$0.46 B |
-0.000 M
|
USA
|
 Axsome Therapeutics
AXSM
|
$5.09 B |
-0.000 M
|
USA
|
| Market Cap | = | RLMD Stock Price | * | RLMD Shares Outstanding |
| = | $0.29 | * | 33.19 M | |
| = | $9.62 M |